FineMark National Bank & Trust - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 80 filers reported holding REVANCE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
FineMark National Bank & Trust ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$35,000
-74.6%
1,700
-80.0%
0.00%
-80.0%
Q3 2016$138,000
+885.7%
8,500
+750.0%
0.02%
+650.0%
Q2 2016$14,000
-17.6%
1,0000.0%0.00%0.0%
Q1 2016$17,000
-50.0%
1,0000.0%0.00%
-50.0%
Q4 2015$34,000
-43.3%
1,000
-50.0%
0.00%
-50.0%
Q3 2015$60,000
-6.2%
2,0000.0%0.01%0.0%
Q2 2015$64,000
+56.1%
2,0000.0%0.01%
+33.3%
Q1 2015$41,000
+20.6%
2,0000.0%0.01%
+20.0%
Q4 2014$34,000
-12.8%
2,0000.0%0.01%
-16.7%
Q3 2014$39,0002,0000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders